Akari Therapeutics Plc
AKTXDrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
Frequently asked questions
What is in Akari Therapeutics Plc's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Akari Therapeutics Plc's (AKTX) pipeline across Phase 3, Phase 2. Its lead program is rVA576 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Akari Therapeutics Plc's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Akari Therapeutics Plc (AKTX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track AKTX biotech catalysts?→
Add AKTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Akari Therapeutics Plc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.